Latest CAMBIA Stories
BRIDGEWATER, N.J., June 8 /PRNewswire/ -- Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company headquartered in New Jersey, announced today that CAMBIA(TM) (diclofenac potassium for oral solution) is now available in the United States for the acute treatment of migraine with or without aura. CAMBIA was approved by the U.S. Food and Drug Administration in June 2009. "The approval and subsequent commercialization of CAMBIA as a unique formulation of diclofenac...
- The navel or umbilicus.
- In Greek archaeology: A central boss, as on a shield, a bowl, etc.
- A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.